Kercheville Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.61M | Sell |
8,483
-165
| -2% | -$129K | 2.28% | 17 |
|
|
2025
Q1 | $7.14M | Buy |
8,648
+435
| +5% | +$359K | 2.91% | 15 |
|
|
2024
Q4 | $6.34M | Sell |
8,213
-327
| -4% | -$252K | 2.46% | 17 |
|
|
2024
Q3 | $7.57M | Buy |
8,540
+795
| +10% | +$704K | 3.19% | 13 |
|
|
2024
Q2 | $7.01M | Buy |
7,745
+1,600
| +26% | +$1.45M | 3.04% | 14 |
|
|
2024
Q1 | $4.78M | Buy |
6,145
+628
| +11% | +$489K | 2.26% | 19 |
|
|
2023
Q4 | $3.22M | Buy |
5,517
+1,995
| +57% | +$1.16M | 1.81% | 20 |
|
|
2023
Q3 | $1.89M | Buy |
+3,522
| New | +$1.89M | 1.2% | 25 |
|
|
2023
Q1 | – | Sell |
-640
| Closed | -$234K | – | 80 |
|
|
2022
Q4 | $234K | Buy |
+640
| New | +$234K | 0.16% | 68 |
|
|
2022
Q2 | – | Sell |
-2,865
| Closed | -$820K | – | 106 |
|
|
2022
Q1 | $820K | Buy |
+2,865
| New | +$820K | 0.39% | 51 |
|